Outcome of Esophagectomy for Cancer in Elderly Patients

Slides:

Advertisements

Similar presentations

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease Srikrishna Sirivella, MD, Isaac Gielchinsky,

Advertisements

Serum C-Reactive Protein as a Predictor of Morbidity and Mortality in Intensive Care Unit Patients After Esophagectomy Michel E. van Genderen, BS, Alexandre.

Brechtje A. Grotenhuis, MD, Pieter van Hagen, MD, Johannes B

Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer

Long-Term Survival of Patients With pN2 Lung Cancer According to the Pattern of Lymphatic Spread Antoine Legras, MD, Pierre Mordant, MD, PhD, Alex Arame,

Niv Ad, MD, Linda Henry, PhD, Sharon Hunt, MBA, Sari D. Holmes, PhD

Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability? Tirone E. David, MD, Susan Armstrong, MS,

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Off-pump Bilateral Skeletonized Internal Thoracic Artery Grafting in Elderly Patients Takeshi Kinoshita, MD, Tohru Asai, MD, PhD, Tomoaki Suzuki, MD,

Hyde M. Russell, MD, Soraya L. Johnson, BS, Katherine C

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

David Badrudin, MD, Feras Khaliel, MD, Raymond Cartier, MD

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis Naoto Morimoto,

Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,

Mitral Valve Repair Is Durable in Patients With Rheumatoid Arthritis

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D

Complex Esophageal Reconstruction Procedures Have Acceptable Outcomes Compared With Routine Esophagectomy Jessica M. Moore, BS, Craig M. Hooker, PhD,

Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer Servet Bölükbas,

Linetta B. Koppert, MD, PhD, Albertus N. van Geel, MD, PhD, Titia E

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Mark D. Iannettoni, MD, William R. Lynch, MD, Kalpaj R

Long-Term Follow-Up After Thoracoabdominal Aortic Aneurysm Repair

Anthony Lemaire, MD, William R

Simple Index to Predict Likelihood of Skilled Nursing Facility Admission After Coronary Artery Bypass Grafting Among Older Patients David C. Chang, PhD,

Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D

Factors Affecting Survival After Mitral Valve Replacement in Patients With Prosthesis– Patient Mismatch Abdulhameed Aziz, MD, Jennifer S. Lawton, MD,

Community-Based Multidisciplinary Computed Tomography Screening Program Improves Lung Cancer Survival Daniel L. Miller, MD, William R. Mayfield, MD,

Long-Term Outcomes After Surgical Resection of Pulmonary Metastases From Colorectal Cancer Hisashi Suzuki, MD, PhD, Moriyuki Kiyoshima, MD, Miyuki Kitahara,

The influence of preoperative weight loss on the postoperative course after esophageal cancer resection Maartje K. van der Schaaf, MD, Hugo W. Tilanus,

Who Do You Say You Are? The Annals of Thoracic Surgery

Use of Amiodarone After Major Lung Resection

Outcomes and Costs for Major Lung Resection in the United States: Which Patients Benefit Most From High-Volume Referral? Elliot Wakeam, MD, MPH, Joseph.

Michael Lanuti, MD, Pierre E

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Serum C-Reactive Protein as a Predictor of Morbidity and Mortality in Intensive Care Unit Patients After Esophagectomy Michel E. van Genderen, BS, Alexandre.

Felix G. Fernandez, MD, Onkar Khullar, MD, Seth D

Primary Cardiac Sarcoma

Outcomes After Transhiatal and Transthoracic Esophagectomy for Cancer

John M. Stulak, MD, Joseph A. Dearani, MD, Harold M

Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.

Redo Aortic Valve Replacement in Children

Radiofrequency Ablation for Stage I Non-Small Cell Lung Cancer: Management of Locoregional Recurrence Michael Lanuti, MD, Amita Sharma, MD, Henning Willers,

Editorial Board, January 2010

Arman Kilic, BS, Matthew J. Schuchert, MD, Brian L

Risk Factors for Local Recurrence and Optimal Length of Esophagectomy in Esophageal Squamous Cell Carcinoma Chang Hyun Kang, MD, PhD, Yoohwa Hwang, MD,

Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer Pamela Samson, MD, MPHS, Varun.

Survival After Isolated Coronary Artery Bypass Grafting in Patients With Severe Left Ventricular Dysfunction Waleed A. Ahmed, MD, Phillip J. Tully, BHSc(Hons),

Age at Repair Affects the Very Long-Term Outcome of Sinus Venosus Defect Giovanni Battista Luciani, MD, Francesca Viscardi, MD, Mara Pilati, MD, Roberto.

Does Timing of Surgical Procedure After Neoadjuvant Chemoradiation Affect Outcomes in Esophageal Cancer? Williams Tessier, MD, Caroline Gronnier, MD,

Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer? Anna Lee, MD, MPH, Andrew T.

Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population Christian McNeely, MD, Stephen.

Invited Commentary The Annals of Thoracic Surgery

Peripheral Vascular Disease as a Predictor of Survival After Coronary Artery Bypass Grafting: Comparison With a Matched General Population Albert H.M.

Pneumonectomy After Chemoradiation Therapy for Non-Small Cell Lung Cancer: Does “Side” Really Matter? Anthony W. Kim, MD, L. Penfield Faber, MD, William.

Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients Staffan Bjessmo, MD,

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery Chuntao Wu, MD, PhD, Edward L. Hannan,

Slide Tracheoplasty in Infants and Children: Risk Factors for Prolonged Postoperative Ventilatory Support Peter B. Manning, MD, Michael J. Rutter, MD,

Vanessa A. Olbrecht, BA, Christopher J. Barreiro, MD, Pramod N

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Esophagectomy for T1 Esophageal Cancer: Outcomes in 100 Patients and Implications for Endoscopic Therapy Arjun Pennathur, MD, Andrew Farkas, BA, Alyssa.

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Risk of Valve-Related Events After Aortic Valve Repair

Surgical Outcomes of Acute Type A Aortic Dissection in Elderly Patients Kazunori Komatsu, MD, Tamaki Takano, MD, PhD, Takamitsu Terasaki, MD, Yuko Wada,

Presentation transcript:

Outcome of Esophagectomy for Cancer in Elderly Patients Tanja M. Cijs, MD, Cees Verhoef, MD, PhD, Ewout W. Steyerberg, PhD, Linetta B. Koppert, MD, PhD, T.C. Khe Tran, MD, Bas P.L. Wijnhoven, MD, PhD, Hugo W. Tilanus, MD, PhD, Jeroen de Jonge, MD, PhD The Annals of Thoracic Surgery Volume 90, Issue 3, Pages 900-907 (September 2010) DOI: 10.1016/j.athoracsur.2010.05.039 Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Overall and cancer specific 5-year survival for patients less than 70 years of age and patients more than 70 years of age. The expected survival of the normal Dutch population with the same age and sex distribution at the time of surgery is indicated as reference. Numbers are patients at risk. The difference in cancer-specific survival between patients younger than 70 years and patients older than 70 years of age is statistically significant (p = 0.03). The life loss is represented by the difference between the expected survival and actuarial survival for patients aged 70 years or older. For patients aged less than 70 years, disease-specific survival (solid squares) was 33.7% (median 24.9), and overall survival (open squares) was 29.3% (median 21.5 months). For patients aged 70 years or more, disease-specific survival (solid triangles) was 26.8% (median 20.2 months), and overall survival (open triangles) was 21.7% (median 16.9 months). The Annals of Thoracic Surgery 2010 90, 900-907DOI: (10.1016/j.athoracsur.2010.05.039) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions